Results 211 to 220 of about 280,511 (259)

The immunology of brain tumors

Science Immunology
Brain tumors represent a unique challenge for cancer immunotherapies because of their location in an immune privileged site. However, the brain tumor immune microenvironment is dictated more by tumor type than the location within the brain per se. This feature is reflected by the higher immunogenicity and response to immunotherapies of metastatic brain
Lukas Bunse, Theresa Bunse, Michael Kilian, Francisco J. Quintana, Michael Platten   +4 more
openaire   +2 more sources

Immunology of brain tumors

2012
Brain tumors of different origin, but notably malignant gliomas, are characterized by their immunosuppressive properties which allow them to escape the host's immune surveillance. The activating immune cell ligands that are expressed by tumor cells, together with potentially immunogenic antigens, are overridden by numerous immune inhibitory signals ...
Roth, Patrick, Eisele, Günter, Weller, Michael   +2 more
openaire   +4 more sources

Predictive Models in Tumor Immunology

2008
The role of the immune system in tumor surveillance is clearly established, and tumor immunologists are actively working to devise preventive and therapeutical vaccines against cancer; however, the growth of biological knowledge is still too slow to win the war against cancer as soon as possible.
LOLLINI, PIER LUIGI, PALLADINI, ARIANNA, F. Pappalardo, S. Motta   +3 more
openaire   +3 more sources

Tumor Immunology and Interferon

Southern Medical Journal, 1978
Host defense mechanisms against cancer depend on an intact cellular immunity system. Immunosurveillance depends on thymus lymphocytes which, when sensitized, form lymphokines. One of the important lymphokines produced by T-lymphocytes is called interferon, well known for its antiviral effects.
openaire   +2 more sources

Tumor immunology and immunotherapy

The Laryngoscope, 1977
AbstractTumor cells contain a variety of antigens, including tumor associated antigens. The tumor associated antigens can be clinically useful as marker's for detection of cancer and some may also mediate host resistance against tumor growth. Much emphasis has been placed on the detection of circulating tumor associated markers, with radioimmunoassays ...
openaire   +2 more sources

Complement And Tumor Immunology

1971
Publisher Summary This chapter provides an overview of the theoretical considerations and practical applications of complement research to tumor immunology in each of five projects—namely, (1) the immunological cell receptors, (2) immune adherence, (3) C1 fixation and transfer test, (4) complement fixation test, and (5) immune cytotoxicity test ...
openaire   +2 more sources

Tumor Immunology

JAMA, 1982
THE RESULTS of experiments in laboratory animals clearly demonstrate that tumor tissues transplanted between rodents possessing identical histocompatibility antigens can lead to immunologic rejection of the tumor. This has led many investigators to propose that tumors, including spontaneously occurring tumors in man, must result, at least in part, from
openaire   +1 more source

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L. Siegel, Jill S. Barnholtz-Sloan, Carol Kruchko   +2 more
exaly  

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Heather Parsons, Atish D. Choudhury, Michael L Cheng   +2 more
exaly  

Tumor Immunology: An Overview

Annals of the New York Academy of Sciences, 1993
I, Hellström, K E, Hellström
openaire   +2 more sources